Lauren Santye, Assistant Editor

CT-P10 is indicated to treat rheumatoid arthritis, non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, granulomatosis with polyangiitis, and microscopic polyangi.

Accumulation of gene mutations occurs in some patients with rheumatoid arthritis, study finds.

An estimated 200 orphan drug designation requests are pending FDA review.

Agency announces action plan to clear backlog of orphan drug designation requests awaiting review.

The CEO of the Cutaneous Lymphoma Foundation describes the challenges of living with the disease.

Sarilumab (Kevzara) is a humanized monoclonal antibody that treats moderate-to-severe active RA.

Study explores the impact of tumor mutation burden and PD-L1 status in immunotherapy response.

The guidelines aim to reduce the risk of infection in patients administered anti-rheumatic medication.

Top news of the day from across the health care landscape.

More than 1.1 million Americans are HIV-positive, yet 15% are unaware of their status.

The new tool aims to help patients make more informed treatment decisions and manage expectations following a cancer diagnosis.

Combining oncolytic virotherapy with PD-1 blockades shows promise treating rhabdomyosarcoma.

The tool can help reduce the cost of treatment for rheumatoid arthritis.

Top news of the day from across the health care landscape.

Investigational drug demonstrates a substantial and clinically meaningful reduction in bleeds related to hemophilia.

The National HIV Testing Day annual campaign takes place on June 27th.

Data suggests favorable tolerability of novel treatment in patients with relapsed or refractory AML.

Rational design approaches could transform how multiple sclerosis is treated.

Top news of the day from across the health care landscape.

Adding an investigational diabetes drug to anti-cancer regimen may reduce cardiotoxicity.

CT-P10 is indicated to treat a form of non-Hodgkin lymphoma and rheumatoid arthritis.

A Complete Response Letter cited issues related to violations within a McPherson, KS, facility.

The presence of a specific protein is crucial to balance the immune system in the gut.

Differences in major risk factors and inequalities in health care access have resulted in substantial disparities in liver cancer mortality.

The guideline reinforces stereotactic body radiation therapy as the standard of care for medically inoperable patients with non-small cell lung cancer.

Scientists solve protein structures to reveal new treatment developments for diseases such as Ebola virus, Lyme disease, and tuberculosis .

Top news of the day from across the health care landscape.

The opioid crisis is a major concern worldwide, with overdoses accounting for the number 1 cause of accidental deaths in the United States.

Targeting KRAS mutations may lead to effective new pancreatic cancer treatments.

New analysis examines opioid use among patients with rheumatoid arthritis.